|
CollPlant Biotechnologies Ltd. (CLGN) DCF Valuation
IL | Healthcare | Biotechnology | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
CollPlant Biotechnologies Ltd. (CLGN) Bundle
Looking to determine the intrinsic value of CollPlant Biotechnologies Ltd.? Our (CLGN) DCF Calculator integrates real-world data with extensive customization options, enabling you to refine your forecasts and enhance your investment strategies.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .6 | 1.7 | 4.2 | .1 | 3.0 | 4.5 | 6.7 | 10.1 | 15.2 | 22.9 |
| Revenue Growth, % | 0 | 164.75 | 154.86 | -98.09 | 3565.22 | 50.48 | 50.48 | 50.48 | 50.48 | 50.48 |
| EBITDA | -1.9 | -1.3 | .2 | -4.3 | -1.7 | -3.0 | -4.5 | -6.8 | -10.2 | -15.3 |
| EBITDA, % | -305.95 | -80.48 | 5.36 | -5358.19 | -58.49 | -66.72 | -66.72 | -66.72 | -66.72 | -66.72 |
| Depreciation | .1 | .2 | .2 | .3 | .3 | 1.3 | 2.0 | 3.0 | 4.5 | 6.8 |
| Depreciation, % | 23.25 | 10.75 | 4.94 | 359.87 | 10.06 | 29.8 | 29.8 | 29.8 | 29.8 | 29.8 |
| EBIT | -2.1 | -1.5 | .0 | -4.6 | -2.0 | -3.2 | -4.8 | -7.3 | -11.0 | -16.5 |
| EBIT, % | -329.21 | -91.23 | 0.41557 | -5718.06 | -68.55 | -71.87 | -71.87 | -71.87 | -71.87 | -71.87 |
| Total Cash | 1.0 | .9 | 11.7 | 8.0 | 7.2 | 4.1 | 6.1 | 9.2 | 13.9 | 20.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .2 | .1 | .0 | .1 | .2 | .3 | .5 | .8 | 1.2 |
| Account Receivables, % | 3.41 | 13.52 | 1.73 | 3.01 | 3.59 | 5.05 | 5.05 | 5.05 | 5.05 | 5.05 |
| Inventories | .2 | .3 | .3 | .4 | .2 | 1.5 | 2.3 | 3.5 | 5.3 | 7.9 |
| Inventories, % | 38.31 | 20.56 | 6.91 | 478.26 | 6.52 | 34.46 | 34.46 | 34.46 | 34.46 | 34.46 |
| Accounts Payable | .2 | .2 | .3 | .3 | .3 | 1.5 | 2.2 | 3.3 | 5.0 | 7.5 |
| Accounts Payable, % | 35.94 | 13 | 6.61 | 378.93 | 8.94 | 32.9 | 32.9 | 32.9 | 32.9 | 32.9 |
| Capital Expenditure | -.4 | -.1 | -.4 | -.4 | -.3 | -1.7 | -2.6 | -3.9 | -5.8 | -8.8 |
| Capital Expenditure, % | -64.32 | -8.46 | -10.16 | -440.13 | -8.71 | -38.33 | -38.33 | -38.33 | -38.33 | -38.33 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -2.7 | -1.5 | .0 | -4.6 | -2.0 | -3.2 | -4.8 | -7.3 | -10.9 | -16.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -3.0 | -1.8 | .1 | -4.7 | -1.9 | -3.9 | -5.6 | -8.4 | -12.6 | -18.9 |
| WACC, % | 6.68 | 6.68 | 6.68 | 6.68 | 6.68 | 6.68 | 6.68 | 6.68 | 6.68 | 6.68 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -38.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -19 | |||||||||
| Terminal Value | -412 | |||||||||
| Present Terminal Value | -298 | |||||||||
| Enterprise Value | -337 | |||||||||
| Net Debt | -6 | |||||||||
| Equity Value | -331 | |||||||||
| Diluted Shares Outstanding, MM | 11 | |||||||||
| Equity Value Per Share | -29.03 |
What You Will Get
- Real CollPlant Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on CollPlant’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.
Key Features
- Comprehensive Data: CollPlant's historical financial records and pre-filled projections.
- Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Insights: Observe CollPlant's intrinsic value recalibrating instantly.
- Intuitive Visualizations: Dashboard graphs illustrate valuation outcomes and essential metrics.
- Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered CollPlant Biotechnologies Ltd. (CLGN) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for CollPlant Biotechnologies Ltd. (CLGN)’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for CollPlant Biotechnologies Ltd. (CLGN)?
- Accuracy: Utilizes real CollPlant financials for reliable data.
- Flexibility: Allows users to easily adjust and test different inputs.
- Time-Saving: Avoid the complexities of creating a DCF model from the ground up.
- Professional-Grade: Crafted with the precision and usability expected by CFOs.
- User-Friendly: Intuitive interface suitable for users without extensive financial modeling skills.
Who Should Use This Product?
- Biotech Investors: Develop comprehensive and accurate valuation models for portfolio assessment in the biotech sector.
- Corporate Strategy Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights for CollPlant Biotechnologies Ltd. (CLGN) to clients.
- Students and Educators: Utilize real-time data for practicing and teaching financial modeling in biotechnology.
- Healthcare Enthusiasts: Gain insights into how biotech companies like CollPlant are valued in the marketplace.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled CollPlant Biotechnologies Ltd. (CLGN) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for CollPlant Biotechnologies Ltd. (CLGN).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.